Use of decision models in the development of evidence-based clinical preventive services recommendations: Methods of the U.S. Preventive Services Task Force

Annals of Internal Medicine

Volumn 165, Issue 7, 2016, Pages 501-508

  Owens, Douglas K ^a   Whitlock, Evelyn P ^b   Henderson, Jillian ^c   Pignone, Michael P ^d   Krist, Alex H ^e   Bibbins Domingo, Kirsten ^f   Curry, Susan J ^g   Davidson, Karina W ^h   Ebell, Mark ⁱ   Gillman, Matthew W ^j   Grossman, David C ^k   Kemper, Alex R ^l   Kurth, Ann E ^m   MacIosek, Michael ⁿ   Siu, Albert L ^o   LeFevre, Michael L ^p  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Fairfax Family Medicine Residency   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h Department of Medicine   (United States)

ⁱ UNIVERSITY OF GEORGIA   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k GROUP HEALTH RESEARCH INSTITUTE   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m YALE UNIVERSITY SCHOOL OF NURSING   (United States)

ⁿ Health Partners   (United States)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p University of Missouri   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; CLINICAL DEVELOPMENT PLAN; EVIDENCE BASED PRACTICE; HISTORICAL RESEARCH; HUMAN; METHODOLOGY; MILITARY PHENOMENA; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); UNITED STATES; ADVISORY COMMITTEE; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE;

ADVISORY COMMITTEES; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84990062641     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2531     Document Type: Article

References (32)

1. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. JAMA. 2016;315:1-12. doi: 10.1001/jama.2016.5989
2. Siu AL; U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:279-96. [PMID: 26757170] doi:10 .7326/M15-2886
3. Moyer VA; U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880-91. [PMID: 22711081] doi: 10.7326/0003-4819-156-12-201206190-00424
4. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330-8. [PMID: 24378917] doi:10 .7326/M13-2771
5. Bibbins-Domingo K; U.S. Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colo-rectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:836-45. [PMID: 27064677] doi: 10.7326/M16-0577
6. Habbema JD, Wilt TJ, Etzioni R, Nelson HD, Schechter CB, Lawrence WF, et al. Models in the development of clinical practice guidelines. Ann Intern Med. 2014;161:812-8. [PMID: 25437409] doi: 10.7326/M14-0845
7. Caro JJ, Briggs AH, Siebert U, Kuntz KM; ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling good research practices-overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Value Health. 2012;15:796-803. [PMID: 22999128] doi:10.1016/j.jval.2012.06.012
8. Sox HC, Higgins MC, Owens DK. Medical Decision Making. 2nd ed. Chichester, United Kingdom: J Wiley; 2013.
9. Dehmer SP, Maciosek MV, Flottemesch, TJ. Aspirin Use to Prevent Cardiovascular Disease and Cancer: A Decision Analysis. AHRQ publication no. 15-05229-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2015.
10. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21-35. [PMID: 11306229]
11. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119:3976-83. [PMID: 24037918] doi:10.1002/cncr.28326
12. Moyer VA; U.S. Preventive Services Task Force. Screening for HIV: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:51-60. [PMID: 23698354] doi:10.7326 /0003-4819-159-1-201307020-00645
13. LeFevre ML; U.S. Preventive Services Task Force. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;162:641-50. [PMID: 25798805] doi:10.7326/M15-0483
14. Siu AL; U.S. Preventive Services Task Force. Behavioral and phar-macotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163:622-34. [PMID: 26389730] doi:10.7326/M15-2023
15. U.S. Preventive Services Task Force. Procedure Manual. Rock-ville, MD: U.S. Preventive Services Task Force; 2015.
16. Zauber A, Knudsen A, Rutter CM, Lansdorp-Vogelaar I, Kuntz KM. Evaluating the Benefits and Harms of Colorectal Cancer Screening Strategies: A Collaborative Modeling Approach. AHRQ publication no. 14-05203-EF-2. Rockville, MD: Agency for Healthcare Research and Quality; 2015.
17. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:311-20. [PMID: 24379002] doi:10.7326/M13-2316
18. Roberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M; ISPOR-SMDM Modeling Good Research Practices Task Force. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Value Health. 2012;15: 804-11. [PMID: 22999129] doi:10.1016/j.jval.2012.06.016
19. Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, et al; ISPOR-SMDM Modeling Good Research Practices Task Force. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value Health. 2012;15:828-34. [PMID: 22999132] doi:10.1016/j.jval.2012 .06.011
20. Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Möller J; ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4. Value Health. 2012;15: 821-7. [PMID: 22999131] doi:10.1016/j.jval.2012.04.013
21. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15:835-42. [PMID: 22999133] doi:10.1016/j.jval .2012.04.014
22. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR-SMDM Modeling Good Research Practices Task Force. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Value Health. 2012;15:843-50. [PMID: 22999134] doi:10.1016/j.jval.2012 .04.012
23. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making. 2012;32:690-700. [PMID: 22990084]
24. Kuntz K, Sainfort F, Butler M, Taylor B, Kulasingam S, Gregory S, et al. Decision and Simulation Modeling in Systematic Reviews. Rock-ville, MD: Agency for Healthcare Research and Quality; 2013.
25. Whitlock EP, Williams SB, Burda BU, Feightner A, Beil T. Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms. A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence synthesis no. 132. AHRQ publication no. 13-05193-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2015.
26. Ades AE, Caldwell DM, Reken S, Welton NJ, Sutton AJ, Dias S. Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making. 2013;33:679-91. [PMID: 23804511] doi:10.1177/ 0272989X13485156
27. Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews. Washington, DC: National Academies Pr; 2011.
28. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Pr; 2011.
29. Saha S, Hoerger TJ, Pignone MP, Teutsch SM, Helfand M, Man-delblatt JS; Cost Work Group, Third US Preventive Services Task Force. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. Am J Prev Med. 2001;20:36-43. [PMID: 11306230]
30. Pignone M, Saha S, Hoerger T, Lohr KN, Teutsch S, Mandelblatt J. Challenges in systematic reviews of economic analyses. Ann Intern Med. 2005;142:1073-9. [PMID: 15968032]
31. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Care Excellence; 2013.
32. Sainfort F, Kuntz KM, Gregory S, Butler M, Taylor BC, Kulasingam S, et al. Adding decision models to systematic reviews: informing a framework for deciding when and how to do so. Value Health. 2013; 16:133-9. [PMID: 23337224] doi:10.1016/j.jval.2012.09.009